key considerations for advanced therapies manufacturing
Published 4 years ago • 114 plays • Length 19:31Download video MP4
Download video MP3
Similar videos
-
35:33
key considerations for maximizing lv and aav production in transient transfection workflows
-
31:10
the impact of rapid virus quantification in the development and manufacture of advanced therapies
-
16:04
an innovative, closed, car t-cell therapy platform process to streamline manufacturing....
-
27:14
viral clearance: a wuxi advanced therapies perspective
-
31:48
efficient and scalable gmp manufacture of aav and lv with transit virusgen® reagent and enhancers
-
22:33
wuxi advanced therapies virology operations: cell & gene therapy vector regulatory testing
-
24:29
meeting regulatory requirements for cell and gene therapy manufacturing
-
33:07
accelerate cell and gene therapy development and increase manufacturing capacity....
-
1:00:26
"monoclonal antibody manufacturing: transforming our most important biologics manufacturing process"
-
1:01:36
t-cells for the win with adaptimmune's adrian rawcliffe
-
15:27
gene therapy -- the time is now: nick leschly at tedxboston
-
20:34
technology-ready processes for gene therapy manufacturing 2.0
-
59:28
gene therapy manufacturing advances with aruvant cto dr. palani palaniappan
-
23:46
aseptic filling for gene therapies and next generation biologics within closed robotic workcells
-
1:26:07
webinar: what are advanced therapies?
-
57:04
in-house manufacturing capabilities gives cell and gene therapy developers a competitive advantage
-
13:23
manufacturing automation for patient-scale cell therapies
-
45:39
therapeutic modalities: business and manufacturing strategies influencing...
-
38:30
enabling large-scale production of viral vectors in the gibco™ cts lv-max lentiviral....
-
59:41
the role of new technologies in enabling cell and gene therapies
-
1:01:23
biologics cmc considerations for advanced therapies – cell and gene
-
19:04
the expanding dna and gene therapy market